Jump to:
Jacob Green joined the corporate department of Ropes & Gray’s New York office in 2021. He specializes in assisting companies with matters relating to the generation, use and sale of IP assets. Jacob provides tailored advice to companies at all stages, including how best to approach the management of patent and trademark portfolios. His clients range from local start-ups to multinational corporations, from venture capital funds to financial institutions. Jacob provides strategic guidance for IP-specific issues in investments, mergers, and acquisitions. Because of this, he is able to provide valuable insight into all aspects of the IP lifecycle, from ideation to monetization.
Before joining the firm, Jacob worked as a lawyer at a leading Canadian intellectual property boutique, where he advised international clients on patent protection and IP-forward business strategies.
Jacob has hands-on educational and professional experience working with cutting-edge technology. Prior to his career in law, Jacob gained valuable experience working at companies large and small. Jacob was an inventor at a world-leading toy company and an electronics designer at an early-stage drone start-up. In these roles, he worked in product management, software design, and hardware development.
Experience
- Represented a provider of oncology testing services in an acquisition of a laboratory.
- Represented Great Gray Group, an independent leader in retirement solutions and the parent company of Great Gray Trust Company, in its acquisition of Retirement Plan Advisory Group (“RPAG”).
- Represented FairJourney Biologics S.A., leaders in the discovery and optimization of antibodies, in its acquisition of the South San Francisco site from Charles River Laboratories International, Inc.
- Represented Aquiline Capital Partners, a leading private equity firm, in several transactions including:
- in a definitive agreement to acquire SEI's Family Office Services business for $120 million.
- in its investment in Health Prime International, a provider of revenue cycle management solutions for physician practices.
- in its majority investment in Pharma Force Group LLC, a pharmacy solutions provider to hospitals and health clinics.
- Represented New Mountain Capital, an alternative investment firm, in several transactions including:
- on its partnership with Amerit Fleet Solutions, a premier provider of commercial fleet maintenance and repair services.
- and its portfolio company Pearce Services, on Pearce's acquisition of Unified Power, a provider of preventative maintenance and repair services for power systems.
- in its strategic investment in Consor Holdings, a leading provider of transportation and water infrastructure engineering and consulting services.
- Represented Planview®, a leading platform for Strategic Portfolio Management (SPM) and Digital Product Development (DPD), in its completed acquisition of Sciforma, a provider of Project Portfolio Management (PPM) and Product Development solutions.
- Represented ZeroFox and Haveli Investments, its controlling sponsor, in the divestment of its subsidiary, IDX, to Kingswood Capital Management. IDX specializes in post-breach forensics, incident response, and regulatory compliance support.
- Represented H.I.G. Capital, a leading global alternative investment firm, in several transactions including:
- and Thoma Bravo in a definitive agreement to acquire the brand and products of Computing Technology Industry Association (CompTIA), a world-leading information technology certification and training business.
- in its acquisition of the distribution business of Avient, a global provider of sustainable and specialized material solutions, for US$950 million.
- Represented Bain Capital Life Sciences as it led an over $200 million strategic growth transaction centered on Serán Bioscience, a leading contract development and manufacturing organization (CDMO) providing development, analytical and manufacturing services to pharmaceutical and biotechnology companies.
- Represented Genstar Capital in its majority investment in Flourish Research, an NMS Capital portfolio company and leading multi-site clinical trial organization focused on cardiovascular, metabolic, neuroscience, and infectious disease therapeutic areas.
- Represented Sodiaal, France's leading dairy cooperative and owner of the Yoplait yogurt brand, as IP transactions counsel and US M&A counsel in an agreement to acquire General Mills' Canadian yogurt business.
- Represented MediQuant, LLC in a strategic investment from Revelstoke Capital Partners, a healthcare-focused private equity firm.
- Represented a pharmaceutical company in an agreement to acquire a company focused on developing treatment options for patients with heart failure.
- Represented Riveron, a business advisory firm backed by Kohlberg & Company, in the acquisition of Yantra.
- Represented a department store corporation in a joint venture with a global brands operator.
- Represented a pharmaceutical company in the acquisition of a private biotechnology company focused on bispecific antibodies for immune diseases.
- Represented Access Information Management (Access) in the acquisition of Triyam, a rapidly-growing software business that provides expert data management solutions for healthcare organizations.
- Represented Cadre Holdings in its $106.5 million acquisition of Alpha Safety Intermediate, a provider of specialized safety products and services focused on the nuclear industry.
- Represented a pharmaceutical company in the acquisition of a therapeutic discovery company that designs new genes for innovative gene therapies.
- Represented TPG in its agreement to acquire Nextech, a leading provider of clinical and administrative healthcare technology solutions for specialty physician practices, from Thomas H. Lee Partners for $1.4 billion.
- Represented Crosspoint Capital in the acquisition of Absolute Software, a provider of self-healing, intelligent security solutions.
- Represented Advent International, a leading global private equity investor, in several transactions including:
- and Warburg Pincus in their investment in Baxter International Inc.'s BioPharma Solutions (BPS) business. Under the terms of the definitive agreement, Baxter will receive $4.25 billion in cash, subject to certain closing adjustments.
- in its US$1.6 billion acquisition of Forescout Technologies, a cybersecurity company.
- Represented Audax Private Equity in its growth investment in Pyramid Laboratories, Inc. a leading drug product contract development and manufacturing organization.
- Represented Goldfinch Bio in an exclusive global license agreement with Karuna Therapeutics under which Karuna will have development, manufacturing and commercialization rights to Goldfinch's therapeutic candidates as potential treatments for various psychiatric and neurological conditions.
- Represented Natixis Investment Managers in its sale of AlphaSimplex, a manager of liquid alternative investment solutions to Virtus Investment Partners.
- Represented CIVC Partners LP in its investment in Continuum Companies, in partnership with CEO Marcus Mayo and certain members of the Continuum management team.
- Represented Fidelity Investments in its joint venture with Vanguard, Alight Solutions and Retirement Clearinghouse, LLC to create a consortium of workplace retirement plan recordkeepers to offer autoportability services.
- Represented Altamont Capital Partners in its acquisition of Service Minds, a provider of electrical, plumbing and HVAC services based in Sarasota, Florida.
- Represented Kohlberg & Company and its portfolio company MarketCast in the add-on acquisition of Phoenix Marketing International.
- Represented Forescout Technologies, Inc. (a portfolio company of Advent International and Crosspoint Capital Partners) in its acquisition of CyberMDX, a leading healthcare cybersecurity provider delivering visibility and threat prevention for medical devices and clinical networks.
- Represented Partners Group in its investment in GHO Capital Partners’ portfolio company Sterling Pharma Solutions, a global Contract Development and Manufacturing Organization.